Pharming Group reports financial results for the first nine months of 2021
Pharming Group presents its preliminary (unaudited) financial report for the first nine months ended September 30, 2021.
The Company held a presentation for analysts at 13:30CET/07:30ET on 28 October 2021. To watch the recording of the call please follow the link below:
The call slides are available for download below.
"I look forward to the read-out of the registration enabling study for leniolisib, expected early in the new year, as a product with transformational potential for APDS patient’s lives and also transformational commercial potential for Pharming."- Sijmen de Vries - CEO